Thioglycolic Acid

Thioglycolic Acid

SCHEMBL2106064

CCCCCC(O)O.O=C(O)CS.O=C(O)CS

nearest known ligand 0.53

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR84 Q9NQS5 10/20 0.53
FFAR1 O14842 3/20 0.52
FFAR4 Q5NUL3 2/20 0.52
PPARD Q03181 5/20 0.45
MAPT P10636 2/20 0.45
LCK P06239 1/20 0.45
ZDHHC20 Q5W0Z9 1/20 0.45
ZDHHC2 Q9UIJ5 1/20 0.45
AKR1B1 P15121 1/20 0.44
KMT2A Q03164 2/20 0.43
PPARG P37231 4/20 0.43
PPARA Q07869 4/20 0.43
TSHR P16473 3/20 0.43
HDAC11 Q96DB2 3/20 0.43
ALDH1A1 P00352 2/20 0.43
TDP1 Q9NUW8 2/20 0.43
SLC22A6 Q4U2R8 1/20 0.43
SLC22A8 Q8TCC7 1/20 0.43
TLR2 O60603 1/20 0.43
MEN1 O00255 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Propionic Acid SCHEMBL4831353 0.86 GPR84 (0.57) GPR84FFAR1FFAR4PPARDMAPT
Propionic Acid SCHEMBL28477972 0.86 GPR84 (0.57) GPR84FFAR1FFAR4PPARDMAPT
Bicarbonate SCHEMBL154438 0.86 GPR84 (0.60) GPR84FFAR1FFAR4PPARDMAPT
Bicarbonate SCHEMBL28737083 0.86 GPR84 (0.60) GPR84FFAR1FFAR4PPARDMAPT
Succinic Acid SCHEMBL29780365 0.84 FFAR4 (0.64) GPR84FFAR1FFAR4PPARDAKR1B1
Malonic Acid SCHEMBL30377870 0.84 GPR84 (0.55) GPR84FFAR1FFAR4PPARDMAPT
Succinic Acid SCHEMBL4667883 0.84 FFAR4 (0.64) GPR84FFAR1FFAR4PPARDAKR1B1
Thioglycolic Acid SCHEMBL632804 0.84 HDAC1 (0.44) GPR84FFAR1FFAR4TSHRALDH1A1
Thioglycolic Acid SCHEMBL30416273 0.84 HDAC1 (0.44) GPR84FFAR1FFAR4TSHRALDH1A1
Acetic Acid SCHEMBL15793456 0.84 GPR84 (0.58) GPR84FFAR1FFAR4PPARDMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 255 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119431650-A Methacrylic polymer and preparation method thereof 拓烯科技(衢州)有限公司 2025-02-14 CN claimed
US-11635692-B2 Resist underlying film forming composition NISSAN CHEMICAL CORPORATION (JP) 2023-04-25 US claimed
US-4093780-A ESTERS AND POLYESTERS OF THIOGLYCOLIC ACID NORANDA MINES LIMITED (CA) 1978-06-06 US claimed
JP-60108430-A None JP disclosed
JP-60106834-A None JP disclosed
CN-122080301-A Optical-grade methacrylic polymer, and preparation method and application thereof 2026-05-26 CN disclosed
WO-2026100231-A1 CURABLE RESIN COMPOSITION, ADHESIVE, SEALING MATERIAL, CURED PRODUCT, SEMICONDUCTOR DEVICE, AND ELECTRONIC COMPONENT ナミックス株式会社 2026-05-15 WO disclosed
US-12624279-B2 Quantum dot-containing polymerizable composition, cured product, wavelength conversion member, backlight unit, and liquid crystal display device FUJIFILM CORPORATION (JP) 2026-05-12 US disclosed
EP-4703778-A1 WAVELENGTH CONVERSION SHEET, BACKLIGHT, AND LIQUID CRYSTAL DISPLAY DEVICE Dai Nippon Printing Co., Ltd. (JP) 2026-03-04 EP disclosed
US-12565548-B2 Compound, polymerizable composition, and cured product FUJIFILM CORPORATION (JP) 2026-03-03 US disclosed
EP-4202505-B1 BARRIER FILM, AND WAVELENGTH CONVERSION SHEET, BACKLIGHT, AND LIQUID CRYSTAL DISPLAY DEVICE IN WHICH SAME IS USED, AS WELL AS METHOD FOR SELECTING BARRIER FILM DAINIPPON PRINTING CO LTD (JP) 2026-02-18 EP disclosed
US-20070172742-A1 Volume hologram recording material and volume hologram recording medium TOAGOSEI CO., LTD. (JP) 2007-07-26 US disclosed
EP-1731975-A1 VOLUME HOLOGRAM RECORDING MATERIAL AND VOLUME HOLOGRAM RECORDING MEDIUM TOAGOSEI CO., LTD. (JP) 2006-12-13 EP disclosed
EP-1729184-A1 VOLUME HOLOGRAM RECORDING MATERIAL AND VOLUME HOLOGRAM RECORDING MEDIUM TOAGOSEI CO., LTD. (JP) 2006-12-06 EP disclosed
US-20060229376-A1 Curable resin composition, photosensitive pattern-forming curable resin composition,color filter, substrate for liquid crystalline panel, and liquid crystalline panel DAI NIPPON PRINTING CO., LTD. (JP) 2006-10-12 US disclosed
US-20030118922-A1 Curable resin for photo-patterning, process for producing the same, curable resin composition, color filter, liquid crystal panel substrate, and liquid crystal panel DAI NIPPON PRINTING CO., LTD. (JP) 2003-06-26 US disclosed
US-6103830-A A TRANSPARENT METHYL METHACRYLATE COPOLYMER; WEATHERABILITY AND SURFACE GLOSS, RIGIDITY, AND BRIGHTNESS OF COLOR TONE; COPOLYMERIZED IN PRESENCE OF A PARTIALLY HYDROGENATED POLYMER CONSISTING OF CONJUGATED DIENE UNITS ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) 2000-08-15 US disclosed
JP-S60108430-A COMPOSITION CURABLE AT ORDINARY TEMPERATURE SHOWA HIGHPOLYMER CO LTD 1985-06-13 JP disclosed
JP-S60106834-A ROOM TEMPERATURE-CURABLE COMPOSITION SHOWA HIGHPOLYMER CO LTD 1985-06-12 JP disclosed
US-4093780-A ESTERS AND POLYESTERS OF THIOGLYCOLIC ACID NORANDA MINES LIMITED (CA) 1978-06-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12624279-B2 Quantum dot-containing polymerizable composition, cured product, wavelength conversion member, backlight unit, and liquid crystal display device NLRP1, NLRP3, ALAD GPR84 2592/4885FFAR1 1689/4885FFAR4 1885/4885
US-12565548-B2 Compound, polymerizable composition, and cured product SEM1, PSMA1, RER1 GPR84 3222/4885FFAR1 517/4885FFAR4 2439/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.